Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 1;62(31):e202303202.
doi: 10.1002/anie.202303202. Epub 2023 Jun 22.

Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug Conjugates

Affiliations

Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug Conjugates

Linda Cerofolini et al. Angew Chem Int Ed Engl. .

Abstract

Several protein-drug conjugates are currently being used in cancer therapy. These conjugates rely on cytotoxic organic compounds that are covalently attached to the carrier proteins or that interact with them via non-covalent interactions. Human transthyretin (TTR), a physiological protein, has already been identified as a possible carrier protein for the delivery of cytotoxic drugs. Here we show the structure-guided development of a new stable cytotoxic molecule based on a known strong binder of TTR and a well-established anticancer drug. This example is used to demonstrate the importance of the integration of multiple biophysical and structural techniques, encompassing microscale thermophoresis, X-ray crystallography and NMR. In particular, we show that solid-state NMR has the ability to reveal effects caused by ligand binding which are more easily relatable to structural and dynamical alterations that impact the stability of macromolecular complexes.

Keywords: Drug Delivery; Drug Design; NMR Spectroscopy; Protein-Drug Conjugates; Structural Biology.

PubMed Disclaimer

References

    1. P. Akkapeddi, S.-A. Azizi, A. M. Freedy, P. M. S. D. Cal, P. M. P. Gois, G. J. L. Bernardes, Chem. Sci. 2016, 7, 2954-2963.
    1. R. V. J. Chari, M. L. Miller, W. C. Widdison, Angew. Chem. Int. Ed. 2014, 53, 3796-3827.
    1. J. M. Harris, R. B. Chess, Nat. Rev. Drug Discovery 2003, 2, 214-221.
    1. P. Caravan, N. J. Cloutier, M. T. Greenfield, S. A. McDermid, S. U. Dunham, J. W. M. Bulte, J. C. Amedio, R. J. Looby, R. M. Supkowski, W. D. Horrocks, T. J. McMurry, R. B. Lauffer, J. Am. Chem. Soc. 2002, 124, 3152-3162.
    1. J. Huang, B. Wu, Z. Zhou, S. Hu, H. Xu, Y. Piao, H. Zheng, J. Tang, X. Liu, Y. Shen, Nanomedicine: Nanotechnol. Biol. Med. 2019, 21, 102058.

Substances

LinkOut - more resources